Literature DB >> 29073642

Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease.

Subhojit Roy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29073642     DOI： 10.1038/nn.4660

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

1.  α-synuclein multimers cluster synaptic vesicles and attenuate recycling.

Authors:  Lina Wang; Utpal Das; David A Scott; Yong Tang; Pamela J McLean; Subhojit Roy
Journal:  Curr Biol       Date:  2014-09-25       Impact factor: 10.834

2.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration.

Authors:  David A Scott; Iustin Tabarean; Yong Tang; Anna Cartier; Eliezer Masliah; Subhojit Roy
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

4.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

5.  Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.

Authors:  Deniz Kirik; Lucy E Annett; Corinna Burger; Nicholas Muzyczka; Ronald J Mandel; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

6.  Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

Authors:  Michael L Kramer; Walter J Schulz-Schaeffer
Journal:  J Neurosci       Date:  2007-02-07       Impact factor: 6.167

7.  α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis.

Authors:  David Scott; Subhojit Roy
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

8.  Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.

Authors:  Marta Martinez-Vicente; Zsolt Talloczy; Susmita Kaushik; Ashish C Massey; Joseph Mazzulli; Eugene V Mosharov; Roberto Hodara; Ross Fredenburg; Du-Chu Wu; Antonia Follenzi; William Dauer; Serge Przedborski; Harry Ischiropoulos; Peter T Lansbury; David Sulzer; Ana Maria Cuervo
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

10.  Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration.

Authors:  Danielle E Mor; Elpida Tsika; Joseph R Mazzulli; Neal S Gould; Hanna Kim; Malcolm J Daniels; Shachee Doshi; Preetika Gupta; Jennifer L Grossman; Victor X Tan; Robert G Kalb; Kim A Caldwell; Guy A Caldwell; John H Wolfe; Harry Ischiropoulos
Journal:  Nat Neurosci       Date:  2017-09-18       Impact factor: 24.884
View more
  7 in total

1.  Modeling the Progression of Cardiac Catecholamine Deficiency in Lewy Body Diseases.

Authors:  David S Goldstein; Mark J Pekker; Patti Sullivan; Risa Isonaka; Yehonatan Sharabi
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

2.  α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability.

Authors:  Abeer Dagra; Douglas R Miller; Min Lin; Adithya Gopinath; Fatemeh Shaerzadeh; Sharonda Harris; Zachary A Sorrentino; Jonatan Fullerton Støier; Sophia Velasco; Janelle Azar; Adetola R Alonge; Joseph J Lebowitz; Brittany Ulm; Mengfei Bu; Carissa A Hansen; Nikhil Urs; Benoit I Giasson; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-08-18

Review 3.  Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.

Authors:  Jessika C Bridi; Frank Hirth
Journal:  Front Neurosci       Date:  2018-02-19       Impact factor: 4.677

4.  Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases.

Authors:  Kathrin Kaehler; Hartwig Seitter; Adolf M Sandbichler; Bettina Tschugg; Gerald J Obermair; Nadia Stefanova; Alexandra Koschak
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

Review 5.  Neurovascular Inflammaging in Health and Disease.

Authors:  Ádám Mészáros; Kinga Molnár; Bernát Nógrádi; Zsófia Hernádi; Ádám Nyúl-Tóth; Imola Wilhelm; István A Krizbai
Journal:  Cells       Date:  2020-07-04       Impact factor: 6.600

Review 6.  Impaired dopamine metabolism in Parkinson's disease pathogenesis.

Authors:  Anna Masato; Nicoletta Plotegher; Daniela Boassa; Luigi Bubacco
Journal:  Mol Neurodegener       Date:  2019-08-20       Impact factor: 14.195

Review 7.  A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.

Authors:  Jun Ho Lee; Hong Jun Kim; Jong Uk Kim; Tae Han Yook; Kyeong Han Kim; Joo Young Lee; Gabsik Yang
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.